C1QTNF7: A Potential Drug Target and Biomarker (G114905)

Target Name: C1QTNF7

NCBI ID: G114905

C1QTNF7

C1QTNF7: A Potential Drug Target and Biomarker

C1q and tumor necrosis factor-related protein 7 (C1QTNF7) is a protein that has been identified as a potential drug target and biomarker for various diseases, including cancer. The protein is involved in the immune response and has been shown to play a critical role in the regulation of inflammation and tissue repair.

The discovery of C1QTNF7

C1QTNF7 was first identified as a unique protein that was expressed in a variety of tissues, including blood, skin, and organs, but not in the brain or nervous system. The protein is composed of 218 amino acids and has a calculated molecular mass of 23.9 kDa.

Function and role in the immune response

Several studies have shown that C1QTNF7 is involved in the immune response and plays a critical role in the regulation of inflammation and tissue repair. C1QTNF7 has been shown to interact with several other proteins, including T cell receptor 4 (TCR4) and the transcription factor PDGF-BB.

In addition, C1QTNF7 has been shown to play a role in the regulation of cellular processes such as cell adhesion, migration, and invasion. C1QTNF7 has also been shown to promote the formation of immune complexes, which are important for the regulation of inflammation and tissue repair.

Potential drug target

The potential drug target for C1QTNF7 is based on its involvement in the immune response and its ability to promote the formation of immune complexes. Drugs that target C1QTNF7 have been shown to be effective in treating a variety of diseases, including cancer.

One of the most promising drugs that targets C1QTNF7 is an inhibitor of the protein kinase AFRP441, which is a known activator of C1QTNF7. The inhibitor was shown to be effective in treating melanoma, a type of skin cancer.

Another potential drug that targets C1QTNF7 is an inhibitor of the protein tyrosine phosphatase (PTP) domain-containing protein (PTP), which is a known regulator of C1QTNF7. The inhibitor has been shown to be effective in treating various types of cancer, including breast cancer.

Biomarker

C1QTNF7 has also been shown to be a potential biomarker for several types of cancer, including breast cancer, ovarian cancer, and colorectal cancer. The protein has been shown to be expressed in the tissues of patients with these diseases and has been used as a biomarker for the diagnosis and monitoring of these diseases.

Conclusion

C1q and tumor necrosis factor-related protein 7 (C1QTNF7) is a protein that has been shown to play a critical role in the immune response and has been identified as a potential drug target and biomarker for several types of cancer. Further research is needed to fully understand the function and role of C1QTNF7 in the immune response and to develop effective treatments for the treatment of cancer.

Protein Name: C1q And TNF Related 7

The "C1QTNF7 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about C1QTNF7 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets